5.85% -0.47

Diamedica Therapeutics Inc (DMAC)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Finanzdaten der Diamedica Therapeutics Inc-Aktie (DMAC)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Research and Development	2.08% 8.153	7.987	6.699	6.437	5.822
Operating Income/Loss	0.15% -10.50	-10.48	-9.213	-9.033	-8.007
Income/Loss From Continuing Operations Before Tax	0.97% -10.13	-10.04	-8.73	-8.614	-7.693
Income Tax Expense/Benefit	0.00% 0.007	0.007	0.01	0.006	0.006
Net Income/Loss	0.97% -10.14	-10.04	-8.74	-8.62	-7.699
Basic Average Shares	0.19% 53.89	53.79	-	49.63	42.96
Basic Earnings Per Share	0.00% -0.19	-0.19	-	-0.17	-0.18

OLMA

$6.58

4.22%

ZVRA

$9.94

3.21%

SLDB

$5.53

3.66%

AVTX

$11.27

6.16%

NVCT

$18.60

1.74%

WVE

$3.13

1.88%